MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Ovarian cancer screening

Back to overy Blogs list Cancer blog  


Subscribe To Overy RSS Feed  RSS content feed What is RSS feed?

Ovarian cancer screening




The only available screening tests for ovary cancer fail to catch early signs of the disease and often result in unnecessary surgery, said scientists at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.

The newly released study looked at a screening regimen that combines ultrasound and a blood test for CA-125, a marker for women's cancer.

Results showed the combo screening caught 70 percent of the ovary cancers in their late stages, when effective therapy options are limited.

Knowing this screening limitation means the search has intensified for a better way to detect ovary cancer, often called the "silent killer," said Edward Partridge, M.D., director of the UAB Comprehensive Cancer Center and the lead study author.



Ovarian cancer screening

"We still have some comparison data to review, but right now it looks like the positive predictive value of these tests is pretty low," Partridge said.

The study puts the positivity value for both tests at around 1.6 percent per 100 positive screening results, a remarkably low positivity rate that led to a number of false positives, he said. False positives are erroneous signals of cancer where there is none.

The UAB results are published April 1 in the journal Obstetrics & Genecology.

Searching For Stronger Clues.

One alarming trend noted in the study is how often transvaginal ultrasound led to a high rate of unnecessary removal of the ovaries, which means no cancer was detected in these organs post-surgery.

"This data suggests that we need a better screening tool. We need a test that is more sensitive and more specific so we find the cancer earlier and we catch the biological markers that give us stronger clues," Partridge said.

The study was part of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO trial) and included more than 72,000 women aged 55 to 74.

The PLCO results coincide with a British study published March 10 online in The Lancet Oncology that found combo screening for ovary cancer was extremely successful in finding early stage cancers. But that still doesn't mean the screens led to a reduction in the ovary cancer death rate, reported the British study authors from the University College London.

Ovary cancer ranks as the fifth leading cause of female cancer death, and it is diagnosed primarily in women aged 55 and older. Early stages of the cancer cause somewhat vague symptoms and a number of malignancies go undetected until other organs and tissues are involved.

The UAB study was a partnership between PLCO researchers at the Huntsman Cancer Institute in Salt Lake City; the University of Colorado Cancer Center in Denver; the Washington University School of Medicine in St. Louis; Georgetown University in Washington, D.C.; University of Pittsburgh Medical Center; the Henry Ford Health System in Detroit; the Pacific Health Research Institute in Honolulu; the University of Minnesota in Minneapolis and the National Cancer Institute in Bethesda, Maryland. Funding was from the National Institutes of Health.


Posted by: Emily    Source




Did you know?
The only available screening tests for ovary cancer fail to catch early signs of the disease and often result in unnecessary surgery, said scientists at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center. The newly released study looked at a screening regimen that combines ultrasound and a blood test for CA-125, a marker for women's cancer.

Medicineworld.org: Ovarian cancer screening

Ectopic pregnancy| Hyperemesis gravidarum vomiting of pregnancy| Obgyn| Menopause symptoms| Pre eclampsia| Seizures in pregnancy| Spontaneous abortion miscarriage| Symptoms of pregnancy| Ovariancancer| Ovarian cancer statistics| Risk factors for ovarian cancer| Role of radiation therapy in the treatment of ovarian cancer| Role of screening in ovarian cancer| Staging of ovarian cancer| Symptoms of ovarian cancer| Treatment of advanced stage ovarian cancer| Treatment of early stage ovarian cancer| Treatment of ovarian cancer| Treatment of recurrent ovarian cancer| What causes ovarian cancer| Who is more prone to ovarian cancer|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.